Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies

Akkoc N., CAN G., D'Angelo S., Padula A., Olivieri I.

CURRENT RHEUMATOLOGY REPORTS, cilt.19, sa.2, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19 Sayı: 2
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1007/s11926-017-0633-0
  • Dergi Adı: CURRENT RHEUMATOLOGY REPORTS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Axial spondyloarthritis, Non-radiographic axial spondyloarthritis, Ankylosing spondylitis, Treatment, Treat to target, NSAIDs, DMARDs, TNF inhibitors, Secukinumab, IL-17A, ACTIVE ANKYLOSING-SPONDYLITIS, METHYLPREDNISOLONE PULSE THERAPY, NONSTEROIDAL ANTIINFLAMMATORY DRUGS, REDUCES SPINAL INFLAMMATION, PROOF-OF-CONCEPT, OPEN-LABEL TRIAL, DOUBLE-BLIND, PSORIATIC-ARTHRITIS, INTRAVENOUS METHYLPREDNISOLONE, DISEASE-ACTIVITY
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Purpose of Review This study aims to provide an update on current status of pharmacological therapies in early and advanced stages of axial spondyloarthritis (axSpA), as well as its late onset forms, and to discuss the need for treat to target strategies in this entity.